Zai Lab Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZLAB | ZYME | INVA | VIR | LGND | ZBIO | |
|---|---|---|---|---|---|---|
| Market cap | 2.76B | 1.82B | 1.55B | 1.91B | 6.20B | 1.72B |
| P/E (TTM) | — | — | 5.0 | — | 32.8 | — |
| Forward P/E | -11.7 | 24.0 | 9.7 | -4.5 | 26.0 | -5.7 |
| Price/book | 4.5 | 22.5 | 1.3 | 1.9 | 6.4 | 6.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −19.98% | +42.41% | +25.21% | +99.66% | +67.77% | +2.71% |
| Today | −1.60% | −1.78% | +1.13% | −3.42% | +3.09% | −3.15% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ZLAB news ›Analyzing Zai Lab (NASDAQ:ZLAB) and Cytokinetics (NASDAQ:CYTK)
Cytokinetics (NASDAQ:CYTK – Get Free Report) and Zai Lab (NASDAQ:ZLAB – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their…
Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Zoci is a novel, potential first-in-class antibody-drug conjugate (ADC), that targets Delta-like ligand 3 (DLL3), a validated therapeutic target that is overexpressed in SCLC and is generally associated with poor clinical outcomes. The…
Zai Lab (NASDAQ:ZLAB) Upgraded at Wall Street Zen
Posted by Danessa Lincoln on Sep 29th, 2026 Wall Street Zen upgraded shares of Zai Lab (NASDAQ:ZLAB – Free Report) from a sell rating to a hold rating in a report published on Saturday,Wall Street Zen reports. Read Our Latest Analysis on…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net1
-
themarketsdaily.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.